Cirugía Cardiovascular

Previous Page

Next Page

Page Background

J.M. Arribas

et al.

/ Cir Cardiov. 2016;

23(2)

:70–75

75

Financiación

Parte

de

los

pacientes

de

este

trabajo

pertenecen

al

estudio

“Foundation”,

patrocinado

por

Edwards

lifesciencies

LLC,

Irvine,

California.

Conflicto de

intereses

JMA y SJC declaran

ser

investigadores del estudio

“Foundation”

patrocinado por Edwards

Lifesciences

LLC,

Irvine, California

Bibliografía

1.

Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence ofa ortic valve abnormalities in the elderly: An echocardiographic study of a

randoms ample. J Am Coll Cardiol. 1993;21:1220– 5.

2.

Baron G, Butchard EG, Delahaye F, Gohlke-Bärwolf C, Lewang OF, et al. A prospective survey of patients with valvular heart disease in Europe: The Euroheart

Survey on valvular heart

disease. Eur Heart J. 2003;24:1231 –43.

3.

BonowR O, Carabello BA, Kanu C, de Leon AC, Faxon

DP, FreedM D, et

al. ACC/AHA 2006 guidelines for the

management of patients with valvular heart disease. Circulation. 2006;114:e84

–

4.

Vahanian A, Alfieri

F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al., ESC Committee for Practice

Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology; European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on theM anagemento fV alvular Heart Disease ofT he European Society ofC ardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac

2012;42:S1 –44.

5.

Schwarz F, Bauman

P, Manthey J, Hoffmann M,

Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation.

–

6.

Kulik A, Tran A, Hendry

et al. Long term clinical and hemodynamic performance of the Hancock II versus the perimount aortic bioprostheses. Circulation. 2010;122

–

7.

Valfrè C, Ius P, Minniti G, Salvador L, Bottio T, Cesari F, et al. The fate of Han- cock II porcine valve recipients

25 years after implant.

Cardiothorac Surg. 2010;38:141

–

8.

Society of Thoracic Surgeons. Executive Summary STS Spring 2005 Report. Dis-

ponible

en:

www.sts.org/documents/pdf/Spring2005 STSExecutiveSummary. pdf

9.

Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et

al. Transcat- heter aortic valve implantation in patients who cannot undergo surgery. New Engl J Med. 2010;363:1597 –607.

10.

Smith CR, Leon MB, Mack M, Miller DC, Moses JW, Svensson LG, et al. Trans- catheter versus surgical aortic-valve replacement in high risk patients. N Eng j Med. 2011;364:2187 –98.

11.

Michel P, Goldstone AR, Nashef SA. The logistic

EuroSCORE. Eur Heart J. 2003;24:882 –3.

12.

Roques F, Hammill BG, Peterson ED, Michel P, Grover FL, et al. Vali- dation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery.

Eur J Cardiothorac Surg. 2002;22:101

–

13.

On

line

STS

Risk

Calculator.

[consultado

27

Dic

2014].

Disponible

en:

http://riskcalc.sts.org/de.aspx

14.

Northern

New

England

Cardiovascular

Disease

Study

Group

(NNECDSG)

Risk

Model.

AVR with

or without

CABG.

[consultado

27

Dic

2014].

Disponible

en:

http/

/www.nnecdsg.org/calculator/interactive

AVR2.htm.

15.

Kocher AA, Laufer G, Haverich A, Shrestha M, Walther T, Misfeld M, et al. One-year outcomes of the Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve (TRITON) trial: A prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve

System. J Thorac Cardiovasc Surg. 2013;145:110

–

16.

Epicard Database. Thoracic and Cardiovascular Surgery. 6th ed. Paris, France: The French Society of Thoracic and Cardiovascular Surgery;

17.

McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, Byrne JG, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: Up to 17 years of follow-up in 1000 patients. Ann Thorac

2010;89:1410– 6.

18.

Al-Sarraf N, Thalib L,

Hughes A, Houlihan M, Tolan

et al. Cross clamp time is an independent predictor of mortality and morbidity in lowa nd high-risk cardiac

patients. Int J

–

19.

Salis S, Mazzanti VV, Merli G, Salvi L, Tedesco CC, Veglia F, et al. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J

Cardiothorac Vasc Anesth. 2008;22:8814

–

20.

Tabata M, Umakanthan R, Cohn LH, Bolman RM III, Shekar PS, Chen FY, et al. Early and late

outcomes of 1000 minimally invasive aortic valve

operations. Eur J

Cardiothoracic.

2008;33:537– 41.

21.

MA, Hain J, Bucerius J, Walther T, Gummert JF, et al. Minimal access aortic valve replacement: Effects on

morbidity and resource

utilization. Ann Thorac

2002;74:S1318 –22.

22.

Paredes FA, Cánovas

SJ, Gil O, García-Fuster O, Hornero F, Vázquez A,

et al. Cirugía mínimamente invasiva para el recambio valvular aórtico. Una técnica segura y útil más allá de lo estético.

–

23.

R, Horack M, Gerckens U, Schuler G, Sievert H, et al. Aor- tic regurgitation after transcatheter aortic valve implantation: Incidence and early outcome.

Results fromt he German transcatheter aortic valve interventions registry. Heart. 2011;97:899 –906.

24.

Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, et al. Long term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. The U.K. TAVI (United King- dom Transcatheter aortic valve implantation) Registry. J Am Coll Cardiol. 2011;58:2130 –8.

25.

Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro

G, et al. Incidence and predictors of early and late mortality after transcatheter aor- tic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299 –308.

26.

M, Khawaja MZ, Lorraine L, James R, Saha M, et al.

Paravalvular regurgitatation

one year after transcatheter

aortic valve implantation. Catheter Cardiovasc Interv. 2010;75:868 –72.

27.

Zagorski B, Christakis

GT, Joiner CD, Vincent J, Sever J, et al. Are stentless valves hemodynamically

superior to stented valves? J Thoracic Cardiovasc Surg. 2010;139:848 –59.

28.

Dalmau MJ, Gonzalez-Santos JM, Blazquez JA, Sastre JA, López-Rodriguez J, Bueno M, et al. Hemodynamic performance of the

Medtronic Mosaic and Peri- mount magna aortic

bioprostheses. Eur J Cardiothorac Surg. 2011;39:844 –52.

29.

Frater RWM, Salomon NW, Rainer WG, Cosgrove DM III, Wickham E. The Carpentier-Edwards pericardial aortic valve: Intermediate results. Ann Thorac Surg. 1992;53:764 –71.